Hardest-to-treat form of TB rare in U.S.: study
By Will Dunham
WASHINGTON (Reuters) - The hardest-to-treat form of drug-resistant tuberculosis is a growing threat in many parts of the world, but remains quite rare in the United States, U.S. government health researchers said on Tuesday.
From 1993 through 2007, there were 83 cases of extensively drug-resistant TB, or XDR-TB, reported in the United States, U.S. Centers for Disease Control and Prevention researchers wrote in the Journal of the American Medical Association.
XDR-TB defies nearly all drugs used to treat tuberculosis, the top cause of infectious disease death among adults worldwide. It is more difficult to treat than the more common multidrug resistant TB, or MDR-TB, which does not respond to the treatment by two or more of the primary drugs used for TB.
Last year, there were two cases of XDR-TB reported in the United States, the researchers said. There were 18 XDR-TB cases detected in 1993 but no more than nine in any year since.
Thirty-five percent of the people with XDR-TB died during treatment. The death rate for XDR-TB was nearly double the rate among MDR-TB cases and more than six times greater than among people with TB that responds to typical drug treatment.
Tuberculosis is an infectious bacterial disease typically attacking the lungs. The emergence and spread of drug-resistant germs makes treating it much harder and more expensive and makes the disease more likely to kill.
Among people with XDR-TB with HIV test results, 53 percent were HIV-positive, the researchers said. Of the XDR-TB cases, 45 percent were foreign born and 40 percent were Hispanic.
CDC epidemiologist Dr. Peter Cegielski, who led the most comprehensive study ever conducted of drug-resistant TB in the United States, warned against complacency.
“As long as there is XDR TB anywhere in the world, there is a risk in the United States, and we have to address the threat. TB doesn’t respect international borders. The TB germs don’t carry passports,” Cegielski said in a telephone interview.
There were 212,896 TB cases from 1993 through 2007, of which 3,379 were classified as MDR-TB and 83 as XDR-TB.
Tuberculosis in the United States was in the spotlight in 2007 when Atlanta lawyer Andrew Speaker triggered an international health scare by flying to and from Europe for his wedding and honeymoon with a drug-resistant form of TB.
He initially was thought to have XDR-TB but it was later determined to be lesser MDR-TB. He was successfully treated.
Globally, cases of drug-resistant tuberculosis are being recorded at the highest rates ever seen, according to the World Health Organization. They account for 5 percent of the 9 million new TB cases annually and are a particular threat in Russia and other former Soviet republics, India, China and South Africa.
The WHO said about 489,000 MDR-TB cases emerged worldwide in 2006, of which about 40,000 were XDR-TB.
(Editing by Julie Steenhuysen and Jackie Frank)
--------------------------------------------------------------------------------------------Related Posts:
By Maggie Fox, Health and Science Editor WASHINGTON (Reuters) - A common strain of influenza circulating in the United States this winter is resistant to Tamiflu, the most popular drug used to treat it, federal health officials said on Friday. The situation poses little danger, according to the U.S. Centers for Disease Control and Prevention, because Tamiflu
Full Post: U.S. flu shows resistance to flu drug, CDC says
--------------------------------------------------------------------------------------------
By Michael Kahn LONDON (Reuters) - A new blood test will allow doctors more accurately to pinpoint patients likely to develop the symptoms of tuberculosis, researchers said on Monday. Traditional testing for the disease involves injecting the subject with components of the TB bacterium; a resultant swelling of the skin can signal dormant tuberculosis. Such skin tests are
Full Post: New TB blood test more accurate than skin test
--------------------------------------------------------------------------------------------
LONDON (Reuters) - A dangerous, drug-resistant bacterium normally found in soil and water is on the increase in hospitals worldwide, an infectious disease expert warned on Tuesday. Acinetobacter baumannii is more resistant than the MRSA superbug and accounts for about 30 percent of drug-resistant hospital infections, said Matthew Falagas, director of the Alfa Institute of Biomedical
Full Post: Dangerous bacteria on increase: expert
--------------------------------------------------------------------------------------------
By C. Vidya Shankar, MD CHENNAI, India (Reuters Health) - HIV-positive infants are over 20 times more likely to develop tuberculosis than their HIV-negative counterparts, researchers from South Africa report in the current issue of Clinical Infectious Diseases. “The current status of TB amongst HIV-infected children is still very high,” Dr. Anneke Hesseling from Cape Town told
Full Post: Dual HIV/TB infection common in S. African infants
--------------------------------------------------------------------------------------------
WASHINGTON (Reuters) - The U.S. government has failed to fix all the coordination problems among agencies that helped two men with a drug-resistant form of tuberculosis elude border security in 2007, investigators said on Thursday. The Government Accountability Office said the departments of Homeland Security and Health and Human Services have made changes following incidents involving
Full Post: U.S. faulted over failure to nab TB travelers